secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2024-12-27T23:59:59+00:00
Accession:  0001493152-24-052297
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs receives Nasdaq bid price deficiency notice; 180-day cure period until June 24, 2025
--------------------------------------------------------------------------------

- Received Nasdaq letter on Dec 26, 2024 for bid price below $1.00 for 30 consecutive business days.
- Has until June 24, 2025 to regain compliance by closing at $1.00+ for 10 consecutive business days.
- Company qualifies for potential second 180-day extension due to stockholders' equity >= $5M.
- Failure to regain compliance may lead to delisting from Nasdaq.
- Management states they are working to evidence compliance, but no assurance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000149315224052297/0001493152-24-052297-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000149315224052297/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-052297

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer